YEAR
- 2022.05.19 Controlled Valve Slide-Over Using a Buddy Balloon: "Shoehorn Technique". Hachinohe D, Shitan H, Kaneko U, Kobayashi K, Mitsube K, Kawamura T, Fujita T.Korean Circ J. 2021 Feb;51(2):187-188. doi: 10.4070/kcj.2020.0454
- 2022.04.27 Epigenetic and environmental regulation of adipocyte function. Matsumura Y, Osborne TF, Sakai J.J Biochem. 2022 Apr 27;. doi: 10.1093/jb/mvac033
- 2022.04.13 The serological diversity of serum IgG/IgA/IgM against SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan. Kaneko Y, Sugiyama A, Tanaka T, Fukui K, Taguchi A, Tatsuno K, Nakayama A, Koga K, Kishi Y, Daming W, Qian C, Xia F, He F, Zheng L, Yu Y, Wada Y, Wada Y, Kodama T, Kawamura T.Health Sci Rep. 2022 May;5(3):e572. doi: 10.1002/hsr2.572
- 2022.04.01 Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1. Makino Y, Kamiyama Y, Brown JB, Tanaka T, Murakami R, Teramoto Y, Goto T, Akamatsu S, Terada N, Inoue T, Kodama T, Ogawa O, Kobayashi T.Commun Biol. 2022 Apr 01;5(1):299. doi: 10.1038/s42003-022-03227-w
- 2022.03.31 Structure of the type V-C CRISPR-Cas effector enzyme. Kurihara N, Nakagawa R, Hirano H, Okazaki S, Tomita A, Kobayashi K, Kusakizako T, Nishizawa T, Yamashita K, Scott DA, Nishimasu H, Nureki O.Mol Cell. 2022 Mar 31;. doi: 10.1016/j.molcel.2022.03.006
- 2022.03.26 Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey. Yoshida M, Kobashi Y, Kawamura T, Shimazu Y, Nishikawa Y, Omata F, Zhao T, Yamamoto C, Kaneko Y, Nakayama A, Takita M, Ito N, Kawashima M, Sugiura S, Shibuya K, Iwami S, Kim K, Iwanami S, Kodama T, Tsubokura M.Vaccines (Basel). 2022 Mar 26;10(4). doi: 10.3390/vaccines10040515
- 2022.03.04 Peak IgG antibody titers against SARS-CoV-2 spike protein following immunization with the Pfizer/BioNTech BNT162b2 vaccine. Kobashi Y, Shimazu Y, Kawamura T, Nishikawa Y, Omata F, Kaneko Y, Kodama T, Tsubokura M.Fukushima J Med Sci. 2022 Apr 08;68(1):67-70. doi: 10.5387/fms.2021-28
- 2022.02.18 Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis. Murakami K, Sasaki Y, Asahiyama M, Yano W, Takizawa T, Kamiya W, Matsumura Y, Anai M, Osawa T, Fruchart JC, Fruchart-Najib J, Aburatani H, Sakai J, Kodama T, Tanaka T.Cells. 2022 02 18;11(4). doi: 10.3390/cells11040720
CLOSE